These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20435434)

  • 21. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-dependent lipopolysaccharide-induced iNOS expression and multiorgan failure in rats: effects of melatonin treatment.
    Escames G; López LC; Ortiz F; Ros E; Acuña-Castroviejo D
    Exp Gerontol; 2006 Nov; 41(11):1165-73. PubMed ID: 17049787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
    Chatterjee S; Premachandran S; Shukla J; Poduval TB
    J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombin replacement in patients with sepsis and septic shock.
    Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
    Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cortisol in critically ill patients with sepsis--physiological functions and therapeutic implications].
    Briegel J
    Wien Klin Wochenschr; 2002; 114 Suppl 1():9-19. PubMed ID: 15503552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melatonin protects against oxidative organ injury in a rat model of sepsis.
    Sener G; Toklu H; Kapucu C; Ercan F; Erkanli G; Kaçmaz A; Tilki M; Yeğen BC
    Surg Today; 2005; 35(1):52-9. PubMed ID: 15622465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress.
    De Filippis D; Iuvone T; Esposito G; Steardo L; Arnold GH; Paul AP; De Man Joris G; De Winter Benedicte Y
    J Pineal Res; 2008 Jan; 44(1):45-51. PubMed ID: 18078447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin administration following hemorrhagic shock decreases mortality from subsequent septic challenge.
    Wichmann MW; Haisken JM; Ayala A; Chaudry IH
    J Surg Res; 1996 Oct; 65(2):109-14. PubMed ID: 8903455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.
    Maldonado MD; Murillo-Cabezas F; Terron MP; Flores LJ; Tan DX; Manchester LC; Reiter RJ
    J Pineal Res; 2007 Jan; 42(1):1-11. PubMed ID: 17198533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
    Das UN
    Med Sci Monit; 2003 Aug; 9(8):RA181-92. PubMed ID: 12942044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human pineal physiology and functional significance of melatonin.
    Macchi MM; Bruce JN
    Front Neuroendocrinol; 2004; 25(3-4):177-95. PubMed ID: 15589268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is pituitary failure the real therapeutic target in septic shock?
    Kouatli Y
    Med Hypotheses; 2010 Mar; 74(3):574-7. PubMed ID: 19853383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of levosimendan in sepsis and septic shock.
    Pinto BB; Rehberg S; Ertmer C; Westphal M
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):168-77. PubMed ID: 18443483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin: a pleiotropic molecule regulating inflammation.
    Radogna F; Diederich M; Ghibelli L
    Biochem Pharmacol; 2010 Dec; 80(12):1844-52. PubMed ID: 20696138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin as a potential antihypertensive treatment.
    Simko F; Paulis L
    J Pineal Res; 2007 Apr; 42(4):319-22. PubMed ID: 17439547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin receptors mediate improvements of liver function but not of hepatic perfusion and integrity after hemorrhagic shock in rats.
    Mathes AM; Kubulus D; Weiler J; Bentley A; Waibel L; Wolf B; Bauer I; Rensing H
    Crit Care Med; 2008 Jan; 36(1):24-9. PubMed ID: 18090374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effects of hypertonic saline on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats.
    Shih CC; Chen SJ; Chen A; Wu JY; Liaw WJ; Wu CC
    Crit Care Med; 2008 Jun; 36(6):1864-72. PubMed ID: 18496380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical implications of melatonin: receptor-mediated and receptor-independent actions.
    Reiter RJ; Tan DX; Manchester LC; Pilar Terron M; Flores LJ; Koppisepi S
    Adv Med Sci; 2007; 52():11-28. PubMed ID: 18217386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock.
    Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH
    Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection.
    Guha M; Maity P; Choubey V; Mitra K; Reiter RJ; Bandyopadhyay U
    J Pineal Res; 2007 Nov; 43(4):372-81. PubMed ID: 17910606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.